Blood to brain to the rescue
AUTOR(ES)
Proia, Richard L.
FONTE
American Society for Clinical Investigation
RESUMO
Neurodegeneration occurs in the majority of the more than 40 known lysosomal storage diseases. Since the nervous system in these disorders can be globally affected, effective treatment would require persistent widespread correction. Biffi et al. show such correction is possible in a mouse model of metachromatic leukodystrophy by the transplantation of hematopoietic cells genetically modified to overexpress the missing lysosomal enzyme. The results reveal a nervous system damage-response pathway that can be harnessed to provide therapy to the nervous system in these serious disorders.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=385411Documentos Relacionados
- Rational approaches to breaching the blood-brain barrier.
- Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
- Permeability of the Blood-Brain Barrier to a Rhenacarborane
- Expanding the definition of the blood-brain barrier to protein.
- Blood-brain barrier and new approaches to brain drug delivery.